D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Microsoft
MSFT
|
+$549M |
| 2 |
Tesla
TSLA
|
+$538M |
| 3 |
Pinduoduo
PDD
|
+$357M |
| 4 |
Intel
INTC
|
+$261M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$255M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$398M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$300M |
| 3 |
Procter & Gamble
PG
|
+$281M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 5 |
JPMorgan Chase
JPM
|
+$250M |
Sector Composition
| 1 | Technology | 20.4% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
FuelCell Energy
FCEL
$96.2M
| $28M | 0.03% |
335,783
+43,325
| +15% | +$3.61M |
|
377
C.H. Robinson
CHRW
$14.9B
| $27.9M | 0.03% |
304,891
+167,085
| +121% | +$15.3M |
|
378
Labcorp
LH
$23B
| $27.8M | 0.03% |
137,657
-510,532
| -79% | -$103M |
|
379
Sempra
SRE
$51.8B
| $27.8M | 0.03% |
360,282
+288,910
| +405% | +$22.3M |
|
380
Hanesbrands
HBI
$2.28B
| $27.7M | 0.03% |
4,357,109
+2,122,523
| +95% | +$13.5M |
|
381
Lyft
LYFT
$7.35B
| $27.6M | 0.03% |
2,508,534
-416,021
| -14% | -$4.58M |
|
382
Bank of New York Mellon
BK
$73.4B
| $27.6M | 0.03% |
606,706
-326,664
| -35% | -$14.9M |
|
383
Graphic Packaging
GPK
$6.38B
| $27.3M | 0.03% |
1,228,199
+443,474
| +57% | +$9.87M |
|
384
Texas Pacific Land
TPL
$21B
| $27.3M | 0.03% |
34,902
+29,505
| +547% | +$23.1M |
|
385
Amicus Therapeutics
FOLD
$2.46B
| $27.3M | 0.03% |
2,233,325
-670,171
| -23% | -$8.18M |
|
386
Kornit Digital
KRNT
$680M
| $27.3M | 0.03% |
1,186,556
+165,250
| +16% | +$3.8M |
|
387
Fortune Brands Innovations
FBIN
$7.29B
| $27.2M | 0.03% |
476,424
-632,447
| -57% | -$36.1M |
|
|
ITCI
388
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $27.2M | 0.03% |
513,500
+163,422
| +47% | +$8.65M |
|
389
Chart Industries
GTLS
$8.96B
| $27.2M | 0.03% |
+235,797
| New | +$27.2M |
|
390
J.M. Smucker
SJM
$11.9B
| $27.1M | 0.03% |
170,764
+51,549
| +43% | +$8.17M |
|
391
Amdocs
DOX
$9.44B
| $27M | 0.03% |
297,359
-162,882
| -35% | -$14.8M |
|
392
Iovance Biotherapeutics
IOVA
$861M
| $27M | 0.03% |
4,221,760
+1,526,540
| +57% | +$9.75M |
|
393
Myriad Genetics
MYGN
$643M
| $26.9M | 0.03% |
1,857,300
+100,834
| +6% | +$1.46M |
|
394
Community Health Systems
CYH
$415M
| $26.9M | 0.03% |
6,231,065
-322,198
| -5% | -$1.39M |
|
|
SPLK
395
DELISTED
Splunk Inc
SPLK
| $26.9M | 0.03% |
312,240
-9,920
| -3% | -$854K |
|
396
SS&C Technologies
SSNC
$21.7B
| $26.7M | 0.03% |
513,038
-532,993
| -51% | -$27.7M |
|
397
Omnicell
OMCL
$1.49B
| $26.7M | 0.03% |
528,631
+483,381
| +1,068% | +$24.4M |
|
398
PROG Holdings
PRG
$1.4B
| $26.6M | 0.03% |
1,574,688
+228,342
| +17% | +$3.86M |
|
399
Linde
LIN
$223B
| $26.4M | 0.03% |
80,913
+77,126
| +2,037% | +$25.2M |
|
400
Workiva
WK
$4.56B
| $26.3M | 0.03% |
313,445
-81,982
| -21% | -$6.88M |
|